Table 3 Relationship between the PGP 9.5 expression and microvessel density (MVD) according to the estrogen receptor status and lymph node involvement in invasive ductal carcinoma of the breast
From: The clinicopathological significance of neurogenesis in breast cancer
No. cases | MVD | P value | |
|---|---|---|---|
PGP 9.5 expression total | P = 0.014 | ||
Weak | 54 | 37.15 ± 10.30 | |
Moderate/strong | 35 | 43.11 ± 11.30 | |
ER-positive | P = 0.148 | ||
Weak | 27 | 38.22 ± 10.64 | |
Moderate/strong | 15 | 43.40 ± 11.33 | |
ER-negative | P = 0.045 | ||
Weak | 27 | 36.07 ± 10.03 | |
Moderate/strong | 20 | 42.90 ± 11.56 | |
LN-positive | P = 0.162 | ||
Weak | 24 | 39.13 ± 8.53 | |
Moderage/strong | 18 | 43.56 ± 11.63 | |
LN-negative | P = 0.039 | ||
Weak | 30 | 35.37 ± 11.02 | |
Moderate/strong | 17 | 42.64 ± 11.27 |